• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. PHASIX ST MESH; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. PHASIX ST MESH; SURGICAL MESH Back to Search Results
Catalog Number 1200015
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Hernia (2240)
Date of Event 04/17/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No conclusion can be made.While the clinician has stated the issue to be "definitely related" to the device, based on the information provided we are unable to determine to what extent, if any, the phasix st mesh may have caused or contributed to the patient's hernia recurrence.Recurrence is a known inherent risk of hernia repair surgery.Regarding hernia recurrence the warning section of the instructions-for-use states, "to prevent recurrences when repairing hernias, phasix st mesh must be large enough to provide sufficient overlap beyond the margins of the repair/primary closure.Careful attention to mesh fixation placement and spacing will help prevent excessive tension or gap formation between the mesh and fascial tissue.A review of the manufacturing records was performed and found that the lot was manufactured to specification.If additional information is provided, a supplemental emdr will be submitted.Note: the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.Remains implanted.
 
Event or Problem Description
It was reported to davol that a patient who is part of a clinical study (phasix st clinical study dvl-he-017) experienced a hernia recurrence.On (b)(6) 2016 - the subject patient underwent laparoscopic repair of an umbilical hernia with implant of the phasix st mesh.Intra-abdominal technique was used.Mechanical fixation was used to fixate the mesh.On (b)(6) 2018 - the subject patient was diagnosed with a hernia recurrence via ct scan.Hernia noted to be reducible this recurrence is assessed by the clinician to be moderate in severity and not a serious adverse event, definitely related to the study device and not related to the index procedure.As reported intervention is required, however a revision date has not been scheduled at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHASIX ST MESH
Common Device Name
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC.
100 crossings blvd.
warwick RI 02886
MDR Report Key7848124
Report Number1213643-2018-03028
Device Sequence Number1053025
Product Code OWT
UDI-Device Identifier00801741095290
UDI-Public(01)00801741095290
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
K143380
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Reporter Type Manufacturer
Report Source health professional,other,stu
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/28/2018
Device Catalogue Number1200015
Device Lot NumberHUAU0502
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/15/2018
Initial Report FDA Received Date09/05/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age60 YR
-
-